CB1R in Synthetic Psychoactive Cannabinoids



Status:Recruiting
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 55
Updated:8/26/2018
Start Date:May 1, 2018
End Date:December 2021
Contact:Deepak C D'Souza, M.D.
Email:deepak.dsouza@yale.edu
Phone:203-932-5711

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

CB1R Availability in Synthetic Psychoactive Cannabinoid Users

The purpose of this research study is to determine whether the CB1R availability is lower in
synthetic psychoactive cannabinoid subjects using the most widely available synthetic
psychoactive cannabinoids at the time the study is initiated.


Inclusion:

- Able to provide written consent

- Age 18-55

- Current Synthetic Psychoactive Cannabinoids consumption

Exclusion:

- MRI metal exclusions and claustrophobia

- Education completed is less than 12 years
We found this trial at
1
site
Connecticut Mental Health Center
New Haven, Connecticut 06508
Principal Investigator: Deepak C D'Souza, M.D.
Phone: 203-974-7775
?
mi
from
New Haven, CT
Click here to add this to my saved trials